Comparison of HbA1c Levels in Normal-Weight and Obese  Type 2 Diabetes Mellitus Patients at Dr. Pirngadi General  Hospital, Medan, North Sumatra, Indonesia

Daniela Sagala; Ranatha NH Nainggolan; Suryati Sinurat; Harry Butar-Butar; Jekson Martiar Siahaan

doi:10.26911/theijmed.2024.9.4.802

Authors

Daniela Sagala Medical Study Program, Indonesian Methodist University
Ranatha NH Nainggolan Department of Patology, Indonesian Methodist University
Suryati Sinurat Department of Public Health, Indonesian Methodist University
Harry Butar-Butar Department of surgical, Indonesian Methodist University
Jekson Martiar Siahaan Department of Physiology, Faculty of Medicine, Universitas Methodist Indonesia, Medan

DOI:

https://doi.org/10.26911/theijmed.2024.9.4.802

Abstract

Background: Diabetes mellitus is a collection of metabolic diseases caused by impaired insulin secretion, insulin action, or both so that it has the characteristics of hyperglycemia. Increased will cause a decrease in glucose delivery to the plasma membrane, resulting in insulin resistance in muscle and adipose tissue. This study aimed to compare HbA1c in normal weight and obese individuals with type 2 DM at Dr. Pirngadi hospital.
Subjects and Method: This was a cross-sectional study was conducted at Dr. Pirngadi Hospital, Medan, North Sumatera, Indonesia, on May 2022. A sample of 50 patients diagnosed with Type 2 Diabetes Mellitus (T2DM, HbA1c ≥6.5%). The study variables were HbA1c and body mass index (BMI). Independent t-test was used to compare HbA1c levels between normal weight and obese participants.
Results: HbA1c in type 2 DM patients with obesity (Mean= 11.49; SD= 0.60) is higher than those with normal weight (Mean= 8.71; SD= 0.34), with p= 0.002.
Conclusion: HbA1c in type 2 DM patients with obesity is higher than those with normal weight.

Keywords:

HbA1c, Diabetes Mellitus, Diabetes, Obesity

References

Arania R, Esfandiari F, Triwahyuni T, Hafizhdillah AR (2021). Hubungan antara tekanan darah sistolik dengan kadar hba1c pada pasien diabetes melitus tipe 2 di Klinik Arafah Lampung Tengah. Jurnal Med Mal. 5(2): 124–131. https://doi.org/10.3-3024/jmm.v5i2.4151.

Bijelic R, Balaban J, Milicevic S, Sipka SU (2020). The association of obesity and microvascular complications with glycemic control in patients with type 2 diabetes mellitus. Med Ar (Sarajevo, Bosnia and Herzegovina), 74(1): 14–18. https://doi.org/10.5455/Medarh.-2020.74.14-18.

Charles ED, Neuschwander BA, Pablo Frias J, Kundu S, Luo Y, Tirucherai G S, & Christian R (2019). Pegbelfermin (bms-986036), pegylated fgf21, in patients with obesity and type 2 dia-betes: Results from a randomized phase 2 study. Obesity. 27(1): 41–49. https://doi.org/10.1002/Oby.22344.

Hotimah K, Listiawati E (2023). Hubungan apolipoprotein b dengan hba1c pada pasien diabetes melitus tipe 2 prolanis Raffina Purwakarta. Bali Med J. 10(1): 96–107. https://doi.org/10.36376/b-mj.v10i1.337.

Jennefer J, Gunawan PA (2020). Hubung-an antara hba1c dengan laju filtrasi glomerulus pada pasien diabetes melitus tipe 2 di Rumah Sakit Swasta Jakarta Barat. Tarumanagara Med J. 2(2): 307–314. https://doi.org/10.2-4912/tmj.v3i1.9733.

Khairinisa G, Alamanda C, Herawati I, Ali C (2022). Hubungan hba1c dengan c-reactive protein pada pasien pende-rita diabetes melitus tipe ii yang tidak terkontrol. Anakes: Jurnal Ilmiah Analis Kesehatan. 8(2): 134–143. https://doi.org/10.37012/-Anakes.V8i2.1122

Majid F, Uwan WB, Zakiah M (2020). Hubungan kadar hba1c terhadap laju filtrasi glomerulus dan proteinuria pada penderita diabetes melitus tipe 2. Jurnal Cer 5(4a): 12. https://doi.-org/10.26418/JC.V6i1.43346.

Mellado-Orellana R, Salinas-Lezama E, Sánchez-Herrera D, Guajardo-Loza-no J, Diaz-Greene EJ, Rodriguez Weber FL (2019). Pharmacological treatment of diabetes mellitus type 2 directed to patients with overweight and obesity. Med Inter De Mex, 35(4): 525–536. https://doi.org/10.24245/mim.v35i4.2486.

Samhan M, Aphridasari J, Subandono J (2022). Pengaruh kadar hba1c ter-hadap tingkat kematian pasien covid-19 dengan komorbid diabetes melitus. Plex Med J 1(2): 68–74. https://-doi.org/10.20961/PLEXUS.V1i2.36.

Oktalia A W, Retnaningrum YR, Khotimah S (2021). Hubungan antara penyakit arteri perifer dan kadar hba1c dengan tindakan amputasi ekstremitas pada pasien ulkus kaki diabetik di Rsud Abdul Wahab Sjahranie Samarinda. Jurnal Sains dan Kesehatan. 3(5): 715–721. https://doi.org/10.25026/-JSK.V3i5.641.

Puspita Sari E, Sayekti S (2023). Korelasi kadar hba1c dengan c-reactive protein pasien diabetes melitus tipe 2. Jurnal Sintesis: penelitian sains, terapan dan anal. 4(1). https://doi.-org/10.56399/JST.V4i1.102.

Susanti E, Latifah I, Nugraha AD (2020). Hubungan nilai hba1c dengan laju filtrasi glomerulus (LFG) pada pasien diabetes melitus tipe 2 di Rumah Sakit Pmi – Bogor. Anakes : Jurnal Ilmiah Analisis Kesehatan. 6(2): 194–201. https:-//doi.org/10.37012/ANA-KES.V6i2.373.

Susatyo JA, Saraswati MR (2022). Hubungan antara red cell distribution width (rdw) dengan hba1c pada pasien diabetes melitus tipe 2 dengan gagal jantung di Rsup Prof Dr IG Ngoerah Denpasar. Udayana In Med. 6(2): 41–44. https://doi.org/10.36216/jpd.v6i-2.208.

Widyatmojo H, Samsuria IK, Triwardhani R (2019). Hubungan kadar hba1c dan rasio tg/hdl dengan cystatin-c serum pada pasien diabetes melitus tipe 2. Medica Hospitalia: J Clin Med. 6(2): 86–91. https://doi.org/10.36408/M-hjcm.V6i2.388.

Widyatmoko A, Santyasna WIT (2022). The relationship of obesity to diabetic foot ulcer in type 2 diabetes mellitus patients. Berkala Kedokteran 18(2): 129. https://doi.org/10.20527/Jbk.-V18i2.14477.

Zahra A N, Farida ME (2020). Hubungan kadar hba1c dan kualitas tidur pada pasien diabetes melitus tipe 2. Jurnal Persatuan Per Nas In. 3(3): 189. https://doi.org/10.32419/JPPNI.V3-i3.170